Political insider Jeff Kimbell prognosticates on the outcomes of the 2022 and 2024 US elections and the potential impact on the life sciences community.

A data-driven and sometimes surprising look at the business of Ophthalmology.

Panel: Wiley A. Chambers, MD, Malvina B. Eydelman, MD, Andrew Gitkin, Peter Menziuso, Euan S. Thomson, PhD

Moderator Preeya K. Gupta, MD, engages a panel of inspired leaders who are bringing the future of ophthalmology into focus. Each offers a distinct perspective on the industry and the requirements for bringing innovation into the marketplace.

A diverse, multigenerational panel of investment experts explore the interdependent roles of venture capital, private financing and global strategics in funding the next wave of eye care innovation.

A timely assessment of the real-world data driving a new generation of treatments and medical vs. surgical solutions for patients.

Seven innovative retina and AI companies will showcase the newest treatments and technologies, while panel experts analyze the clinical and market opportunities.

Government, academic, and industry experts offer perspectives on benchmarking practices that accurately characterize the effectiveness of treatments in clinical studies and meet regulatory requirements.